Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells.
about
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future ApplicationsCharacterization of a novel anti-cancer compound for astrocytomasStem cells as therapeutic vehicles for the treatment of high-grade gliomas.In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.The art of gene therapy for glioma: a review of the challenging road to the bedsidePropolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell lineFlt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and TemozolomideRelease of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant gliomaSitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.Stem cells and gliomas: past, present, and future.Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma.Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatmentHFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A.Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.Natural products: a hope for glioblastoma patients.
P2860
Q26772309-CBA99996-55F4-40D0-B615-4372196A33E3Q28543237-21B78878-7090-4218-ACEA-1219F034C1ACQ34240433-93D14A2E-67E5-43C1-B8F9-9BA1835CCDA4Q34803686-C34F121C-8F3A-42B8-8EC6-2DDDABEF4C28Q35674453-03E790A2-EE15-40E2-861B-B164C82D6532Q36527593-188E847A-C6EC-4167-BAC8-85817D6BA073Q36687919-2A6781F1-F355-4E59-9AE1-7103C5726F5AQ36994063-3C4F7BFF-C00F-4CA1-A657-170BC76B56EDQ37236243-6A2F8F80-B091-46AE-8845-E54DA15E4D78Q37356520-3A7C19C9-90ED-4463-90EA-406B566F91F8Q37403279-FB7A6798-5DF5-4E37-B386-1DE853BB3185Q37585453-9E9767C0-893B-4F9B-B3C3-1317FE3CD468Q37818222-228CE25C-C3A3-4164-892D-39E66F7E7181Q38235856-D22C318A-645C-4F96-BA9C-7ECDB2178BD9Q38941438-EFA7114F-2173-4317-A152-F7FFDA36003BQ39167592-D7FF04A9-52D3-46EE-A225-30AE8D5478FCQ39614785-C810E400-9E62-4892-9056-92AB5DFDD5BFQ42479312-2D8C5A1E-80A5-4A7D-842D-872538F6BFB7Q55445418-96683B1F-E144-4505-A801-BEE0514E6120
P2860
Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@ast
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@en
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@nl
type
label
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@ast
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@en
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@nl
prefLabel
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@ast
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@en
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@nl
P1476
Enhanced proapoptotic effects ...... lomide-resistant glioma cells.
@en
P2093
Mahmud Uzzaman
P304
P356
10.3171/JNS.2007.106.4.646
P577
2007-04-01T00:00:00Z